Innovation Pharmaceuticals Inc (IPIX)

[slcimmuno]

Doubt it / Many investors seemingly losing a bit of patience - maybe the Aruda sell off at work too but who knows. IMO CTIX a longer term play.

As to Dalbavancin, it only went up against Vanco (not Dapto), had a lower clinical efficacy (high 70s, low 80s) and its side effects/safety profile is not as good as B. (Orativancin slightly better, w activity against VRE, MSSA, MRSA.)

Plenty of room in the ABSSSI mkt esp for a new single-dose drug that is as good as the current leader (Dapto) with resistance less likely to develop.

Link below to a good summary on the competition for ABSSSI. Dalbavancin/Orativancin.

http://mad-id.org/wp-content/uploads/2015/01/2015-Jan-newsletter_Final.pdf